Log In
CQMS
Make a Donation
Log In
Donate

EORTC/TROG 01.03 – Glioblastoma/Temozolomide – 26981/22981

Completed

Concomitant and Adjuvant Temozolomide and Radiotherapy for Newly Diagnosed Glioblastoma Multiforme. A Randomized Phase III Study

Primary Sponsor

EORTC

Collaborating Groups

TROG Cancer Research

Prev Post

TROG 01.04 – Rectal (Phase III)

Next Post

EORTC 22996-24002/TROG 01.01 – EPO Head & Neck

Related Post

DECREASE trial into prostate cancer
8 July, 2025

Recruitment Milestone Achieved for TROG 19.06 DECREASE Trial

TRIAL UPDATE: 8 July 2025 The TROG 19.06 DECREASE

Geoff Zipper - aka Swamp - on the Kokoda Trail
26 June, 2025

Cancer Survivor to Take on Fifth Kokoda trek to Support TROG

LATEST NEWS: 26 June 2025 He may be 76

Register now

For over 30 years, Trans-Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram Bluesky Streamline Icon: https://streamlinehq.com Bluesky

Quick Links

Legalities

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292